Sponsor Pipeline

Jingdong Zhang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07311408 SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure Gastric Cancer (GC) Recruiting
Disease Areas
Gastric Cancer (1)
Get alerts when Jingdong Zhang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free